114 related articles for article (PubMed ID: 11278691)
1. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.
Belletti B; Prisco M; Morrione A; Valentinis B; Navarro M; Baserga R
J Biol Chem; 2001 Apr; 276(17):13867-74. PubMed ID: 11278691
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.
Navarro M; Valentinis B; Belletti B; Romano G; Reiss K; Baserga R
Endocrinology; 2001 Dec; 142(12):5149-57. PubMed ID: 11713209
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.
Valentinis B; Navarro M; Zanocco-Marani T; Edmonds P; McCormick J; Morrione A; Sacchi A; Romano G; Reiss K; Baserga R
J Biol Chem; 2000 Aug; 275(33):25451-9. PubMed ID: 10846175
[TBL] [Abstract][Full Text] [Related]
5. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
6. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Zhang D; Bar-Eli M; Meloche S; Brodt P
J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.
Prisco M; Peruzzi F; Belletti B; Baserga R
Mol Cell Biol; 2001 Aug; 21(16):5447-58. PubMed ID: 11463827
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
11. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
Harada S; Smith RM; Smith JA; White MF; Jarett L
J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
14. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
15. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
[TBL] [Abstract][Full Text] [Related]
16. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway.
Weng LP; Brown JL; Baker KM; Ostrowski MC; Eng C
Hum Mol Genet; 2002 Jul; 11(15):1687-96. PubMed ID: 12095911
[TBL] [Abstract][Full Text] [Related]
17. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
18. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
[TBL] [Abstract][Full Text] [Related]
19. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.
Sciacca L; Prisco M; Wu A; Belfiore A; Vigneri R; Baserga R
Endocrinology; 2003 Jun; 144(6):2650-8. PubMed ID: 12746329
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
